Immunization with heat-killed Mycobacterium bovis bacille Calmette–Guerin (BCG) in Eurocine™ L3 adjuvant protects against tuberculosis
- 19 November 2003
- Vol. 22 (11-12), 1498-1508
- https://doi.org/10.1016/j.vaccine.2003.10.016
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Genetically Determined Disparate Innate and Adaptive Cell-Mediated Immune Responses to PulmonaryMycobacterium bovisBCG Infection in C57BL/6 and BALB/c MiceInfection and Immunity, 2000
- Nasal and parenteral immunizations with diphtheria toxoid using monoglyceride/fatty acid lipid suspensions as adjuvantsVaccine, 1999
- Human cytolytic and interferon γ-secreting CD8+T lymphocytes specific forMycobacterium tuberculosisProceedings of the National Academy of Sciences, 1998
- CTL induction using synthetic peptides delivered in emulsions— critical role of the formulation procedureVaccine, 1997
- Immunogenetics in the analysis of resistance to intracellular pathogensCurrent Opinion in Immunology, 1995
- Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I‐ and II‐deficient knock‐out mice: contribution of CD4 and CD8 T cells to acquired resistanceEuropean Journal of Immunology, 1995
- Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literatureJAMA, 1994
- Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-AnalysisInternational Journal of Epidemiology, 1993
- T Cell Response to Mycobacterium tuberculosisThe Journal of Infectious Diseases, 1993
- Adjuvants — a balance between toxicity and adjuvanticityVaccine, 1993